A novel tuberculosis regimen shortens treatment course for patients
Disparities in COVID-19 rates among adults with kidney failure in New York City
4 June 2021President says Argentina to produce Russian COVID vaccine
4 June 2021A novel tuberculosis regimen shortens treatment course for patients
Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete the lengthy regimen, making it more likely that treatment resistance will develop.
